| Company Name: | Allied Healthcare Products | | Ticker Symbol: | AHPI | | | WWW Address: | www.alliedhpi.com |
| CEO: | Mr. Earl R. Refsland | | No. of Employees: | 289 |
| Common Issue Type: | CS | | Business Description: | Allied Healthcare Products manufactures and markets respiratory products, including respiratory care products, medical gas equipment and emergency medical products.
|
| | | Industry Information: | HEALTH SERVICES - Medical Appliances & Equipment [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 2.55 |  0.04 | 2.48 | 2.63 | 2.5 | 2.63 | 2.49 | 6911 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 20.5 | 8.0 | 0.67 | -0.05 | 0.00 | 0.0 | 0.0 | 3.33 - 2.44 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 2.55 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 20.5 | mil |
| Latest Shares Outstanding | 8.0 | mil |
| Earnings pS (EPS) | -0.05 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 150,331 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 2.9 | mil |
| Float as % of Shares Outstanding | 35.4 | % |
| Foreign Sales | 10 | mil |
| Domestic Sales | 34 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 27.80 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 24.5 | % |
| EBITDA Margin | -3.3 | % |
| Pre-Tax Profit Margin | -5.4 | % |
| Assets Turnover | 1.3 | % |
| Return on Assets (ROA) | -4.5 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -5.2 | % |
| Current Ratio | 4.5 | |
| Leverage Ratio (Assets/Equity) | 1.2 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 1.74 | $ |
| Cash pS | 0.54 | $ |
| Book-Value pS | 3.16 | $ |
| Tangible Book-Value pS | 3.16 | $ |
| Cash Flow pS | 0.00 | $ |
| Free Cash Flow pS | -0.22 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.81 | |
| Price/Tangible Book Ratio | 0.81 | |
| Price/Cash Flow | 1748.9 | |
| Price/Free Cash Flow | -11.4 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -4.0 | 94 | 29 | 238 |
| 4 Weeks | 2.87 | 2.49 | 2.82 | -9.4 | 85 | 20 | 402 |
| 13 Weeks | 3.33 | 2.49 | 2.60 | -1.9 | 89 | 39 | 2,436 |
| 26 Weeks | 3.33 | 2.44 | 2.49 | 2.4 | 84 | 40 | 4,955 |
| 52 Weeks | 3.33 | 2.44 | 3.21 | -20.6 | 62 | 40 | 9,867 |
| YTD | 3.33 | 2.44 | - | -3.0 | 83 | 33 | 3,145 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 2.60 | 2.64 | 2.77 | 2.67 | 2.68 | 0.67 | 0.02 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -6.20 | 93.3 | -4.67 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 2.81 | NA | 11.71 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -13.3 | -13.9 | -7.1 |
| Earnings % | 0.0 | 0.0 | -100.0 |
| EPS % | 0.0 | 0.0 | -100.0 |
| EPS $ | -0.11 | -0.01 | -0.08 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 51.06 |
| Current Ratio | 4.5 |
| Quick Ratio (Acid Test) | 2.2 |
| Liquidity Ratio (Cash) | 1.16 |
| Receivables Turnover | 8.4 |
| Average Collection Period | 43 |
| Working Capital/Equity | 59.8 |
| Working Capital pS | 1.97 |
| Cash-Flow pS | 0.11 |
| Free Cash-Flow pS | -0.15 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 4.61 |
| Financial Leverage Ratio (Assets/Equity) | 1.2 |
| Debt Ratio | 14.6 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 0.0 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.69 |
| Tobin's Q Ratio | 0.65 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | 31.18 |
| Enterprise Value (EV)/Free Cash Flow | -47.73 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 0.81 |
| Price/Book Ratio - LTM | 0.81 |
| Price/Cash Flow Ratio | 1748.9 |
| Price/Free Cash Flow Ratio - LTM | -11.4 |
| Price/Sales Ratio | 0.52 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 0.56 |
| Tangible Book Value pS - LTM | 3.16 |
| Book Value pS - LTM | 3.16 |
| Capital Invested pS | 3.34 |
| Cash pS - LTM | 0.54 |
| Cash Flow pS - LTM | 0.00 |
| Free Cash Flow pS - LTM | -0.22 |
| Earnings pS (EPS) | -0.05 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -2.83 |
| Free Cash Flow Margin 5YEAR AVG | 0.54 |
| Net Profit Margin | -1.0 |
| Net Profit Margin - 5YEAR AVRG. | -6.8 |
| Equity Productivity | 1.62 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 1.62 |
| Return on Capital Invested (ROCI) | -1.6 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -11.1 |
| Assets Productivity | 1.40 |
| Return on Assets (ROA) | -1.4 |
| Return on Assets (ROA) - 5YEAR AVRG. | -9.2 |
| Gross Profit Margin | 24.5 |
| Gross Profit Margin - 5YEAR AVRG. | 26.0 |
| EBITDA Margin - LTM | -3.3 |
| EBIT Margin - LTM | -5.4 |
| Pre-Tax Profit Margin | -1.5 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -7.0 |
| Effective Tax Rate | 36.7 |
| Effective Tax Rate - 5YEAR AVRG. | 29.9 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 156 |
| Revenue per Employee | 150,331 |
| Net Income per Employee | -1,469 |
| Average Collection Period | 41 |
| Receivables Turnover | 8.4 |
| Day's Inventory Turnover Ratio | 115 |
| Inventory Turnover | 3.1 |
| Inventory/Sales | 23.0 |
| Accounts Payble/Sales | 4.14 |
| Assets/Revenue | 0.71 |
| Net Working Capital Turnover | 2.71 |
| Fixed Assets Turnover | 4.03 |
| Total Assets Turnover | 1.4 |
| Revenue per $ Cash | 8.22 |
| Revenue per $ Plant | 4.52 |
| Revenue per $ Common Equity | 1.62 |
| Revenue per $ Capital Invested | 1.62 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 24.4 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 23.8 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |
